Chronic Pain Medical Clinics
1-888-324-MIND
Continuing dexamphetamine for attention deficit-hyperactivity disorder (ADHD) during pregnancy was not associated with a higher likelihood of adverse maternal and neonatal outcomes compared with stopping the medication during pregnancy. A population-based retrospective cohort study from Western Australia found, though, that women who had ceased taking the drug prior to becoming pregnant had the lowest odds of adverse outcomes.
Your email address will not be published. Required fields are marked *
Name*
Email*
Website
Save my name, email, and website in this browser for the next time I comment.